FDA subjects antibiotic to new scrutiny (Associated Press)
14th Nov 2006, 15:39 GMT
A novel antibiotic linked to rare reports of severe liver problems, including several deaths, will be subjected to new scrutiny by federal health advisers, according to a document released Tuesday.
FDA subjects antibiotic to new scrutiny (Associated Press) related news:
- FDA subjects antibiotic to new scrutiny (Associated Press) — Yahoo! Health: Health News
- In wake of deaths, FDA subjects antibiotic to new scrutiny — USATODAY.com Health - Top Stories
- FDA Subjects Antibiotic to New Scrutiny — AP Top Health News At 10:37 a.m.
- FDA subjects antibiotic to new scrutiny (AP) — Yahoo! News: Health News
- FDA subjects antibiotic to new scrutiny in wake of reports of death and injury — WOODTV - Political News
- Sanofi-Aventis Antibiotic Under Scrutiny — WSJ.com: US Business
- The Associated Press Top 25 — WOODTV - Michigan Sports Headlines
- Review of Sanofi Drug Is Sought — WSJ.com: US Business
- Volume 194, number 12: Antibiotic Selection May Contribute to Increases in Macrolide-Resistant Treponema pallidum — J Infect Dis Latest Issue
- FDA urges monitoring of Tamiflu patients — Boston Globe -- National News
Latest news from Yahoo! Health: Health News:
- Simple steps can speed heart attack care: study (Reuters)
- Hospitals want faster heart attack care (Associated Press)
- Diabetes threatens many of world's indigenous people (Reuters)
- Fast test catches heart blockages, U.S. study shows (Reuters)
- Children showing hardening of arteries -U.S. study (Reuters)
- Children showing hardening of arteries: U.S. study (Reuters)
- Two Canada professors win right to toke up at work (Reuters)
- Results mixed on Merck's new painkiller (Associated Press)
- Group gives advice on face transplants (Associated Press)
- Diabetes drug may cut heart risks: study (Reuters)